Department of Biology, School of Science, King Mongkut's Institute of Technology Ladkrabang, Bangkok, 10520, Thailand.
Department of Microbiology, Faculty of Pharmacy, Mahidol University, Phayathai, Bangkok, 10400, Thailand.
Sci Rep. 2023 Mar 24;13(1):4825. doi: 10.1038/s41598-023-32043-3.
Tirandamycin (TAM B) is a tetramic acid antibiotic discovered to be active on a screen designed to find compounds with neuroprotective activity. The producing strain, SBST2-5, is an actinobacterium that was isolated from wastewater treatment bio-sludge compost collected from Suphanburi province, Thailand. Taxonomic characterization based on a polyphasic approach indicates that strain SBST2-5 is a member of the genus Streptomyces and shows low average nucleotide identity (ANI) (81.7%), average amino-acid identity (AAI) (78.5%), and digital DNA-DNA hybridization (dDDH) (25.9%) values to its closest relative, Streptomyces thermoviolaceus NBRC 13905, values that are significantly below the suggested cut-off values for the species delineation, indicating that strain SBST2-5 could be considered to represent a novel species of the genus Streptomyces. The analysis of secondary metabolites biosynthetic gene clusters (smBGCs) in its genome and chemical investigation led to the isolation of TAM B. Interestingly, TAM B at 20 µg/mL displayed a suppressive effect on beta-secretase 1 (BACE1) with 68.69 ± 8.84% inhibition. Molecular docking simulation reveals the interaction mechanism between TAM B and BACE1 that TAM B was buried in the pocket of BACE-1 by interacting with amino acids Thr231, Asp 228, Gln73, Lys 107 via hydrogen bond and Leu30, Tyr71, Phe108, Ile118 via hydrophobic interaction, indicating that TAM B represents a potential active BACE1 inhibitor. Moreover, TAM B can protect the neuron cells significantly (% neuron viability = 83.10 ± 9.83% and 112.72 ± 6.83%) from oxidative stress induced by serum deprivation and Aβ administration models at 1 ng/mL, respectively, without neurotoxicity on murine P19-derived neuron cells nor cytotoxicity against Vero cells. This study was reportedly the first study to show the neuroprotective and BACE1 inhibitory activities of TAM B.
替拉霉素(TAM B)是一种四氢酸抗生素,在筛选具有神经保护活性的化合物的筛选中被发现具有活性。产生菌 SBST2-5 是一种放线菌,从泰国素攀武里省的废水处理生物污泥堆肥中分离出来。基于多相特征的分类学特征表明,菌株 SBST2-5 是链霉菌属的成员,其平均核苷酸同一性(ANI)(81.7%)、平均氨基酸同一性(AAI)(78.5%)和数字 DNA-DNA 杂交(dDDH)(25.9%)与最接近的亲缘关系,即嗜热毁丝霉 NBRC 13905 相比,这些值明显低于种系划分的建议截止值,表明菌株 SBST2-5 可能被认为代表链霉菌属的一个新种。对其基因组中次级代谢产物生物合成基因簇(smBGCs)的分析和化学研究导致了 TAM B 的分离。有趣的是,TAM B 在 20 µg/mL 时对β-分泌酶 1(BACE1)表现出抑制作用,抑制率为 68.69±8.84%。分子对接模拟揭示了 TAM B 与 BACE1 之间的相互作用机制,TAM B 通过与氨基酸 Thr231、Asp 228、Gln73、Lys 107 形成氢键,与 Leu30、Tyr71、Phe108、Ile118 形成疏水相互作用,从而被埋藏在 BACE-1 的口袋中,表明 TAM B 代表一种潜在的 BACE1 抑制剂。此外,TAM B 可以在 1ng/mL 时显著保护神经元细胞免受血清剥夺和 Aβ给药模型诱导的氧化应激(神经元存活率分别为 83.10±9.83%和 112.72±6.83%),而对鼠源性 P19 衍生神经元细胞无神经毒性,对 Vero 细胞也无细胞毒性。这项研究据报道是首次显示 TAM B 的神经保护和 BACE1 抑制活性的研究。